-
-
-
-
-
-
-
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Jefferies says these are the best SMID-cap biotech stocks to buy
-
-
-
-
-
-
-
BeiGene, Ltd. (ONC) Tops Q4 EPS by 42c, provides guidance
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on BeOne Medicines (ONC)
-
-
-
-
-
-
-
BeOne Medicines presents lung cancer data at ESMO 2025
-
-
-
-
-
-
-
BeOne Medicines reports positive results for lymphoma drug sonrotoclax
-
-
-
-
-
-
-
Oncolytics plans FDA talks for pancreatic cancer drug trial
-
448,172 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

